{"paper_id":"0d63c23f-a0c1-4339-adee-fc03fbbf9d02","body_text":"Summary\nTen female patients suffering from catamenial epilepsy were treated with a synthetic analogue of the gonadotrophin releasing hormone (GnRH) in additon to antiepileptic drugs. Three of the patients became seizure free, in four patients seizure frequency decreased and in one patient seizures were of shorter duration. In only two of the patients was there no therapeutic effect. Adverse effects, including hot flushes, headache and increase in weight, were noticed in eight patients. These results support the hypothesis that treatment with a synthetic GnRH analogue might be helpful in patients with intractable catamenial epilepsies.\nSimilar content being viewed by others\nReferences\nAlmquist R (1955) The rhythm of epileptic attacks and its relationship to the menstrual cycle. Munksgaard, Kopenhagen\nAnsell B, Clarke E (1956) Epilepsy and menstruation, the role of water retention. Lancet II:1232–1235\nBöckström T, Landren S, Zetterlund B, Blom S, Dubrovsky B, Bixo M, Södergard R (1984) Effects of ovarian steroid hormones on brain excitability and their relation to epilepsy seizure variation during the menstrual cycle. In: Porter R (ed) Advances in epileptology. Raven Press, New York, pp 269–277\nBonuccelli U, Melis GB, Paoletti AM (1989) Unbalanced progesterone and estradiol secretion in catamenial epilepsy. Epilepsy Res 3:100–106\nComite F, Jensen P (1988) Bone density changes associated with GnRH analogues. Gynecol Endocrinol 2 [Suppl 1]:105\nCoy DH, LaBrie F, Savary M (1975) LH-releasing activity of potent LH-RH analogs in vitro. Biochem Biophys Res Commun 67:576–679\nFeely M, Gibson J (1984) Intermittent clobazam for catamenial epilepsy. J Neurol Neurosurg Psychiatry 47:1279–1282\nFraser HM, Lincoln GA (1980) Effects of chronic treatment with an LHRH agonist on the secretion of LH, FSH and testosterone in the ram. Biol Reprod 22:269–276\nGowers BR (1885) Epilepsy and other chronic convulsive diseases — their causes, symptoms, and treatment. Williamwood, New York\nHerzog AG (1986) Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorderes. Neurology 36:1607–1610\nHerzog AG (1988) Clomiphene therapy in epileptic women with menstrual disorders. Neurology 38:432–434\nJacono JJ, Robertson JM (1987) The effects of estrogen, progesterone, and ionized calcium on seizures during the menstrual cycle of epileptic women. Epilepsia 28:571–577\nKumar N, Behari M, Ahuja GK, Jailkhani BL (1988) Phenytoin levels in catamenial epilepsy. Epilepsia 29:155–158\nLivingston S (1972) Comprehensive management of epilepsy in infancy, childhood and adolescence. Thomas, Springfield, Ill, pp 101–102\nMason-Garcia M, Vigh S, Comaru-Schally AM (1985) Radioimmunoassay for 6-n-tryptophan analog of luteinizing hormone-releasing hormone: measurement of serum level after administration of long-acting microcapsule formulations. Proc Natl Acad Sci USA 82:1547–1550\nMattson RH, Cramer JA, Caldwell BV, Siconolfi BC (1984) Treatment of seizures with medroxyprogesterone acetate: preliminary report. Neurology 34:1255–1258\nMilton JG, Gotman J, Remillard GM, Andermann F (1987) Timing of seizure recurrence in adult epileptic patients: a statistical analysis. Epilepsia 28:471–478\nMurri L, Bonuccelli U, Melis GB (1986) Neuroendocrine evaluation in catamenial epilepsy. Funct Neurol 1:399–403\nNewmark ME, Penry JK (1980) Catamenial epilepsy: a review. Epilepsia 21:281–300\nRosciszewska D, Buntner B, Guz I, Zawisza L (1986) Ovarian hormones, anticonvulsant drugs, and seizures during the menstrual cycle in women with epilepsy. J Neurol Neurosurg Psychiatry 49:47–51\nRubinow DR, Schmidt PJ (1989) Menstrual and formal mood disorders. In: Demers LM, McGuire JL, Phillips A, Rubinow DR (eds) Premenstrual, postpartum, and menopausal mood disorders. Urban & Schwarzenberg, Baltimore Munich, pp 35–51\nSchally AV, Airmura A, Baba Y (1971) Isolation and properties of the FSH and LH releasing hormone. Biochem Biophys Res Commun 43:393–398\nSchmidt D (1981) Effect of antiepileptic drugs on estrogen and progesterone metabolism and on oral contraception. In: Dam M, Gram L, Penry JK (eds) Advances in epileptology: XIIth Epilepsy International Symposium. Raven Press, New York, pp 423–431\nShavit G, Lerman P, Korczyn A, Kivity S, Bechar M, Gitter S (1984) Phenytoin pharmacokinetics in catamenial epilepsy. Neurology 34:959–961\nWaibel-Treber S, Minne HW, Scharla SH (1989) Reversible bone loss in women treated with GnRH agonists for endometriosis and uterine leiomyomya. Hum Reprod 4:384–388\nWildt L, Sir-Petermann T (1989) Physiologic und Pathophysiologie der Ovarialfunktion. Kliniksarzt 18:503–510\nZorn JR, Soubrane O, Siboni O (1987) Medical reversible castration withd-Trp-6-LHRH microcapsules for the treatment of endometriosis. Contrib Gynecol Obst 16:254–259\nAuthor information\nAuthors and Affiliations\nRights and permissions\nAbout this article\nCite this article\nBauer, J., Wild, L., Flügel, D. et al. The effect of a synthetic GnRH analogue on catamenial epilepsy: a study in ten patients. J Neurol 239, 284–286 (1992). https://doi.org/10.1007/BF00810354\nReceived:\nRevised:\nAccepted:\nIssue date:\nDOI: https://doi.org/10.1007/BF00810354","source_license":"CC0","license_restricted":false}